Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Mometasone Allergy Relief
Active Ingredient:	Mometasone furoate monohydrate 0.5173mg/g equivalent to mometasone furoate anhydrous 50mcg/spray
Dosage Form:	Nasal spray solution
New Zealand Sponsor:	PSM Healthcare Limited trading as API Consumer Brands
Manufacturer:	Farmea, Angers, France

*Product:*	Proctasil
Active Ingredients:	Cinchocaine hydrochloride 5mg/g Hydrocortisone 5mg/g
Dosage Form:	Rectal ointment
New Zealand Sponsor:	Nova Pharmaceuticals NZ Limited
Manufacturer:	Mepro Pharmaceuticals Private Limited, Wadhwan City, India

Dated this 31st day of May 2021.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule